The Succinate Dehydrogenase Genetic Testing in a Large Prospective Series of Patients with Paragangliomas

Abstract

SDH genetic testing, including tests for large genomic deletions, is indicated in all patients with head and neck and/or thoracic-abdominal or pelvic paraganglioma and can be targeted according to clinical criteria.